﻿<?xml version="1.0" encoding="utf-8"?>
<Return xmlns="http://www.irs.gov/efile" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.irs.gov/efile" returnVersion="2015v2.1">
  <ReturnHeader binaryAttachmentCnt="0">
    <ReturnTs>2016-09-14T15:52:00-05:00</ReturnTs>
    <TaxPeriodEndDt>2015-12-31</TaxPeriodEndDt>
    <PreparerFirmGrp>
      <PreparerFirmEIN>680037990</PreparerFirmEIN>
      <PreparerFirmName>
        <BusinessNameLine1Txt>GILBERT ASSOCIATES INC</BusinessNameLine1Txt>
      </PreparerFirmName>
      <PreparerUSAddress>
        <AddressLine1Txt>2880 GATEWAY OAKS DR STE 100</AddressLine1Txt>
        <CityNm>SACRAMENTO</CityNm>
        <StateAbbreviationCd>CA</StateAbbreviationCd>
        <ZIPCd>95833</ZIPCd>
      </PreparerUSAddress>
    </PreparerFirmGrp>
    <ReturnTypeCd>990</ReturnTypeCd>
    <TaxPeriodBeginDt>2015-01-01</TaxPeriodBeginDt>
    <Filer>
      <EIN>943068338</EIN>
      <BusinessName>
        <BusinessNameLine1Txt>NATIONAL LYMPHEDEMA NETWORK INC</BusinessNameLine1Txt>
      </BusinessName>
      <BusinessNameControlTxt>NATI</BusinessNameControlTxt>
      <PhoneNum>5108091660</PhoneNum>
      <USAddress>
        <AddressLine1Txt>2288 FULTON STREET NO 307</AddressLine1Txt>
        <CityNm>BERKELEY</CityNm>
        <StateAbbreviationCd>CA</StateAbbreviationCd>
        <ZIPCd>94704</ZIPCd>
      </USAddress>
    </Filer>
    <BusinessOfficerGrp>
      <PersonNm>PATRICIA EGAN MS MBA</PersonNm>
      <PersonTitleTxt>BOARD CHAIR</PersonTitleTxt>
      <PhoneNum>5108091660</PhoneNum>
      <SignatureDt>2016-08-31</SignatureDt>
      <DiscussWithPaidPreparerInd>1</DiscussWithPaidPreparerInd>
    </BusinessOfficerGrp>
    <PreparerPersonGrp>
      <PreparerPersonNm>LINDA D GEERY</PreparerPersonNm>
      <PTIN>P00364484</PTIN>
      <PhoneNum>9166466464</PhoneNum>
    </PreparerPersonGrp>
    <TaxYr>2015</TaxYr>
    <BuildTS>2017-02-10 21:41:12Z</BuildTS>
  </ReturnHeader>
  <ReturnData documentCnt="8">
    <IRS990 documentId="RetDoc1038000001" referenceDocumentId="RetDoc1044400001">
      <AddressChangeInd>X</AddressChangeInd>
      <PrincipalOfficerNm>PATRICIA EGAN MS MBA</PrincipalOfficerNm>
      <USAddress>
        <AddressLine1Txt>2288 FULTON STREET NO 307</AddressLine1Txt>
        <CityNm>BERKELEY</CityNm>
        <StateAbbreviationCd>CA</StateAbbreviationCd>
        <ZIPCd>94704</ZIPCd>
      </USAddress>
      <GrossReceiptsAmt>1293092</GrossReceiptsAmt>
      <GroupReturnForAffiliatesInd>0</GroupReturnForAffiliatesInd>
      <Organization501c3Ind>X</Organization501c3Ind>
      <WebsiteAddressTxt>WWW.LYMPHNET.ORG</WebsiteAddressTxt>
      <TypeOfOrganizationCorpInd>X</TypeOfOrganizationCorpInd>
      <FormationYr>1988</FormationYr>
      <LegalDomicileStateCd>CA</LegalDomicileStateCd>
      <ActivityOrMissionDesc>FOUNDED IN 1988, THE NATIONAL LYMPHEDEMA NETWORK'S MISSION IS TO CREATE AWARENESS OF LYMPHEDEMA THROUGH EDUCATION AND TO PROMOTE AND SUPPORT THE AVAILABILITY OF QUALITY MEDICAL TREATMENT FOR ALL INDIVIDUALS AT RISK FOR OR AFFECTED BY LYMPHEDEMA.</ActivityOrMissionDesc>
      <VotingMembersGoverningBodyCnt>7</VotingMembersGoverningBodyCnt>
      <VotingMembersIndependentCnt>7</VotingMembersIndependentCnt>
      <TotalEmployeeCnt>7</TotalEmployeeCnt>
      <TotalVolunteersCnt>32</TotalVolunteersCnt>
      <TotalGrossUBIAmt>0</TotalGrossUBIAmt>
      <NetUnrelatedBusTxblIncmAmt>0</NetUnrelatedBusTxblIncmAmt>
      <PYContributionsGrantsAmt>148069</PYContributionsGrantsAmt>
      <CYContributionsGrantsAmt>331129</CYContributionsGrantsAmt>
      <PYProgramServiceRevenueAmt>894869</PYProgramServiceRevenueAmt>
      <CYProgramServiceRevenueAmt>950929</CYProgramServiceRevenueAmt>
      <PYInvestmentIncomeAmt>408</PYInvestmentIncomeAmt>
      <CYInvestmentIncomeAmt>234</CYInvestmentIncomeAmt>
      <PYOtherRevenueAmt>23192</PYOtherRevenueAmt>
      <CYOtherRevenueAmt>2151</CYOtherRevenueAmt>
      <PYTotalRevenueAmt>1066538</PYTotalRevenueAmt>
      <CYTotalRevenueAmt>1284443</CYTotalRevenueAmt>
      <PYGrantsAndSimilarPaidAmt>0</PYGrantsAndSimilarPaidAmt>
      <CYGrantsAndSimilarPaidAmt>3880</CYGrantsAndSimilarPaidAmt>
      <PYBenefitsPaidToMembersAmt>0</PYBenefitsPaidToMembersAmt>
      <CYBenefitsPaidToMembersAmt>0</CYBenefitsPaidToMembersAmt>
      <PYSalariesCompEmpBnftPaidAmt>306037</PYSalariesCompEmpBnftPaidAmt>
      <CYSalariesCompEmpBnftPaidAmt>255087</CYSalariesCompEmpBnftPaidAmt>
      <PYTotalProfFndrsngExpnsAmt>0</PYTotalProfFndrsngExpnsAmt>
      <CYTotalProfFndrsngExpnsAmt>0</CYTotalProfFndrsngExpnsAmt>
      <CYTotalFundraisingExpenseAmt>8516</CYTotalFundraisingExpenseAmt>
      <PYOtherExpensesAmt>572223</PYOtherExpensesAmt>
      <CYOtherExpensesAmt>1255703</CYOtherExpensesAmt>
      <PYTotalExpensesAmt>878260</PYTotalExpensesAmt>
      <CYTotalExpensesAmt>1514670</CYTotalExpensesAmt>
      <PYRevenuesLessExpensesAmt>188278</PYRevenuesLessExpensesAmt>
      <CYRevenuesLessExpensesAmt>-230227</CYRevenuesLessExpensesAmt>
      <TotalAssetsBOYAmt>587534</TotalAssetsBOYAmt>
      <TotalAssetsEOYAmt>259036</TotalAssetsEOYAmt>
      <TotalLiabilitiesBOYAmt>277672</TotalLiabilitiesBOYAmt>
      <TotalLiabilitiesEOYAmt>179401</TotalLiabilitiesEOYAmt>
      <NetAssetsOrFundBalancesBOYAmt>309862</NetAssetsOrFundBalancesBOYAmt>
      <NetAssetsOrFundBalancesEOYAmt>79635</NetAssetsOrFundBalancesEOYAmt>
      <InfoInScheduleOPartIIIInd>X</InfoInScheduleOPartIIIInd>
      <MissionDesc>FOUNDED IN 1988, THE NATIONAL LYMPHEDEMA NETWORK'S MISSION IS TO CREATE AWARENESS OF LYMPHEDEMA THROUGH EDUCATION AND TO PROMOTE AND SUPPORT THE AVAILABILITY OF QUALITY MEDICAL TREATMENT FOR ALL INDIVIDUALS AT RISK FOR OR AFFECTED BY LYMPHEDEMA.THE NATIONAL LYMPHEDEMA NETWORK (NLN) IS DEDICATED TO:- PROMOTING RESEARCH INTO THE CAUSES, PREVENTION, AND TREATMENT OF LYMPHEDEMA;- SECURING ADEQUATE INSURANCE COVERAGE FOR MEDICALLY NECESSARY, SAFE, AND EFFECTIVE TREATMENT; AND- EXPANDING THE NUMBER AND GEOGRAPHICAL DISTRIBUTION OF LYMPHEDEMA TREATMENT FACILITIES AND CERTIFIED THERAPISTS.</MissionDesc>
      <SignificantNewProgramSrvcInd>0</SignificantNewProgramSrvcInd>
      <SignificantChangeInd>0</SignificantChangeInd>
      <ExpenseAmt>1414914</ExpenseAmt>
      <GrantAmt>3880</GrantAmt>
      <RevenueAmt>953080</RevenueAmt>
      <Desc>INTERNATIONAL LYMPHEDEMA CONFERENCE:IN 2015, THE NATIONAL LYMPHEDEMA NETWORK JOINTLY ORGANIZED THE 25TH WORLD CONGRESS OF LYMPHOLOGY ALONG WITH THE INTERNATIONAL SOCIETY OF LYMPHOLOGY AND THE SENTINAL LYMPH NODE WORKING GROUP. THIS WAS A HISTORIC UNDERTAKING ON THE OCCASION OF THE 25TH ANNIVERSARY OF THE WORLD CONGRESS OF LYMPHOLOGY. 850 PARTICIPANTS FROM 39 COUNTRIES GATHERED TOGETHER IN SAN FRANCISCO TO HEAR LEADING INTERNATIONAL EXPERTS DISCUSS ADVANCED PATIENT CARE AND TREATMENT DEVELOPMENTS. THE SCIENTIFIC COMMUNITY PRESENTED ADVANCES IN DIAGNOSTIC IMAGING TECHNIQUES, NEW INSIGHTS IN THE PATHOPHYSIOLOGY OF LYMPHEDEMA, AND UPDATES ON CANCER METASTASIS AND THE LYMPHATIC SYSTEM. THE MEDICAL CONFERENCE WAS PLANNED AND IMPLEMENTED IN ACCORDANCE WITH THE ACCREDITATION REQUIREMENTS AND POLICIES OF THE ACCREDITATION COUNCIL FOR CONTINUING MEDICAL EDUCATION THROUGH THE JOINT PROVIDERSHIP OF THE UNIVERSITY OF CHICAGO PRITZKER SCHOOL OF MEDICINE, NORTHSHORE UNIVERSITY HEALTHSYSTEM AND THE NATIONAL LYMPHEDEMA NETWORK. IN ADDITION, A TWO-DAY PATIENT SUMMIT OFFERED A SPECIAL PROGRAM DESIGNED SPECIFICALLY FOR PATIENTS AND THEIR CAREGIVERS, A FORUM FOR LEARNING AND ASKING QUESTIONS OF THE EXPERTS. AS REPORTED IN SCHEDULE R, THE 25TH WORLD CONGRESS OF LYMPHOLOGY WAS ORGANIZED AS A SINGLE-MEMBER LLC UNDER THE NATIONAL LYMPHEDEMA NETWORK.</Desc>
      <ProgSrvcAccomActy2Grp>
        <Desc>MARILYN WESTBROOK GARMENT FUND:SINCE 2007, THE NATIONAL LYMPHEDEMA NETWORK HAS PROVIDED ESSENTIAL COMPRESSION GARMENTS-NOT COVERED BY INSURANCE AND WELL BEYOND THE MEANS OF PATIENTS AND THEIR FAMILIES-TO FINANCIALLY NEEDY PATIENTS. PRESCRIBED COMPRESSION GARMENTS ARE AN ABSOLUTELY NECESSARY PART OF THE DAILY CARE AND MANAGEMENT OF LYMPHEDEMA. YET, MANY IF NOT MOST INSURANCE COMPANIES DO NOT COVER THESE ESSENTIAL ITEMS. IN CONJUNCTION WITH GENEROUS INDUSTRY SPONSORS AND A DEDICATED COMMITTEE OF VOLUNTEER EXPERT THERAPISTS, THE NATIONAL LYMPHEDEMA NETWORK HAS HELPED WELL OVER 1000 PATIENTS TO OBTAIN THE COMPRESSION GARMENTS THAT THEY NEED. IN 2015, THE MARILYN WESTBROOK GARMENT FUND SERVED 332 PATIENTS.</Desc>
      </ProgSrvcAccomActy2Grp>
      <ProgSrvcAccomActy3Grp>
        <Desc>PUBLICATIONS, EDUCATION, AND PATIENT SERVICES:AT THE CENTER OF THE NATIONAL LYMPHEDEMA NETWORK'S SERVICES ARE THE PATIENTS AND THERAPISTS WHO NEED CURRENT INFORMATION ABOUT THE RANGE OF CONDITIONS THAT CONSTITUTE WHAT WE KNOW AS LYMPHEDEMA. TO THIS END, THE NATIONAL LYMPHEDEMA NETWORK PUBLISHES A QUARTERLY JOURNAL, LYMPHLINK, WHICH INCLUDES RESEARCH ARTICLES, A PULL-OUT RESOURCE GUIDE TO THERAPIST TRAINING PROGRAMS, TREATMENT AND DIAGNOSTIC CENTERS, PHYSICIANS, CLINICS, THERAPISTS, SUPPLIERS, AND SUPPORT GROUPS, PATIENT PERSPECTIVES, NEWS, AND UPDATES ABOUT CURRENT TOPICS IN THE FIELD. WE PROVIDE INFORMATION BROCHURES AND SPECIAL TOPIC SHEETS, POSITION PAPERS, AND REPRINTED ARTICLES FOR THERAPIST TRAINING PROGRAMS, SUPPORT GROUPS, AND THOSE WHO CONTACT US THROUGH OUR WEBSITE, FACEBOOK PAGE, AND 800-NUMBER TELEPHONE INFORMATION LINE. THE NATIONAL LYMPHEDEMA NETWORK HOSTS AN EXTENSIVE REFERRAL DATABASE OF QUALIFIED THERAPISTS AND LYMPHEDEMA TREATMENT CENTERS, AVAILABLE FREE ONLINE. THE NLN SUPPORT GROUP NETWORK PROVIDES INFORMATIONAL AND PSYCHOSOCIAL SUPPORT TO PATIENTS, FAMILIES, AND CAREGIVERS, INCLUDING FREE LISTINGS IN LYMPHLINK AND ON THE WEBSITE. NEAR COMPLETION IS AN EDUCATIONAL KIT DESIGNED FOR DISTRIBUTION TO CANCER CENTERS TO ALERT MEDICAL STAFF ABOUT THE RISK OF LYMPHEDEMA ASSOCIATED WITH CANCER TREATMENT. THE NATIONAL LYMPHEDEMA NETWORK HOSTS ACTIVE SOCIAL MEDIA RESOURCES, INCLUDING A PATIENT BLOG, FACEBOOK PAGE, AND TWITTER POSTS.</Desc>
      </ProgSrvcAccomActy3Grp>
      <ProgSrvcAccomActyOtherGrp>
        <Desc>OTHER PROGRAM SERVICES:THE NATIONAL LYMPHEDEMA NETWORK HAS A LONG HISTORY OF COLLABORATION WITH DOMESTIC AND INTERNATIONAL ORGANIZATIONS WITH RELATED GOALS AND MISSIONS. WE COLLABORATE WITH BREAST CANCER ACTION, THE FAT DISORDERS RESEARCH SOCIETY, LYMPHEDEMA ADVOCACY GROUP, LYMPHOLOGY ASSOCIATION OF NORTH AMERICA, NATIONAL ORGANIZATION OF RARE DISORDERS, AND RARE DISEASE LEGISLATIVE ADVOCATES, AMONG OTHERS, TO ADVANCE AWARENESS AND KNOWLEDGE ABOUT LYMPHEDEMA AND RELATED DISEASES AND DISORDERS. WE DEVELOPED THE INTERNATIONALLY RECOGNIZED LYMPH SCIENCE ADVOCACY PROGRAM, A TRAINING PROGRAM FOR PATIENTS AND CAREGIVERS STEPPING UP TO LEADERSHIP POSITIONS IN THEIR COMMUNITIES, REGIONS, AND BEYOND. OUR LYMPHEDEMA AMBASSADORS REACH OUT TO THE GENERAL PUBLIC TO INCREASE AWARENESS AND UNDERSTANDING OF LYMPHEDEMA AND THOSE AFFECTED BY THIS DISEASE GROUP. NLN INTERNATIONAL AFFILIATES ARE FOUND AROUND THE WORLD. IN 1994, THE NLN INITIATED LYMPHEDEMA AWARENESS DAY ON MARCH 6, THE DAY THE NLN WAS FOUNDED. THIS INTERNATIONAL CELEBRATION RECOGNIZES PATIENTS, THERAPISTS, CAREGIVERS, AND POLICYMAKERS WHO MAKE A DIFFERENCE TO THE LYMPHEDEMA COMMUNITY. MARCH IS LYMPHEDEMA AWARENESS MONTH, WITH PROCLAMATIONS BY LOCAL, STATE, AND NATIONAL ORGANIZATIONS. THE NLN MEDICAL ADVISORY COMMITTEE, WITH SUBCOMMITTEES IN EDITORIAL, RESEARCH, AND SCIENTIFIC AREAS, ENSURES THAT MEDICAL AND THERAPEUTIC CONTENT IS CURRENT AND REPRESENTS THE BEST PRACTICES IN THE FIELD.</Desc>
      </ProgSrvcAccomActyOtherGrp>
      <TotalProgramServiceExpensesAmt>1414914</TotalProgramServiceExpensesAmt>
      <DescribedInSection501c3Ind referenceDocumentId="RetDoc1039100001">1</DescribedInSection501c3Ind>
      <ScheduleBRequiredInd referenceDocumentId="RetDoc1234500001">1</ScheduleBRequiredInd>
      <PoliticalCampaignActyInd referenceDocumentId="RetDoc1039500001">0</PoliticalCampaignActyInd>
      <LobbyingActivitiesInd referenceDocumentId="RetDoc1039500001">1</LobbyingActivitiesInd>
      <SubjectToProxyTaxInd referenceDocumentId="RetDoc1039500001">0</SubjectToProxyTaxInd>
      <DonorAdvisedFundInd referenceDocumentId="RetDoc1040000001">0</DonorAdvisedFundInd>
      <ConservationEasementsInd referenceDocumentId="RetDoc1040000001">0</ConservationEasementsInd>
      <CollectionsOfArtInd referenceDocumentId="RetDoc1040000001">0</CollectionsOfArtInd>
      <CreditCounselingInd referenceDocumentId="RetDoc1040000001">0</CreditCounselingInd>
      <TempOrPermanentEndowmentsInd referenceDocumentId="RetDoc1040000001">0</TempOrPermanentEndowmentsInd>
      <ReportLandBuildingEquipmentInd referenceDocumentId="RetDoc1040000001">1</ReportLandBuildingEquipmentInd>
      <ReportInvestmentsOtherSecInd referenceDocumentId="RetDoc1040000001">0</ReportInvestmentsOtherSecInd>
      <ReportProgramRelatedInvstInd referenceDocumentId="RetDoc1040000001">0</ReportProgramRelatedInvstInd>
      <ReportOtherAssetsInd referenceDocumentId="RetDoc1040000001">0</ReportOtherAssetsInd>
      <ReportOtherLiabilitiesInd referenceDocumentId="RetDoc1040000001">0</ReportOtherLiabilitiesInd>
      <IncludeFIN48FootnoteInd referenceDocumentId="RetDoc1040000001">1</IncludeFIN48FootnoteInd>
      <IndependentAuditFinclStmtInd referenceDocumentId="RetDoc1040000001">0</IndependentAuditFinclStmtInd>
      <ConsolidatedAuditFinclStmtInd referenceDocumentId="RetDoc1040000001">1</ConsolidatedAuditFinclStmtInd>
      <SchoolOperatingInd>0</SchoolOperatingInd>
      <ForeignOfficeInd>0</ForeignOfficeInd>
      <ForeignActivitiesInd>0</ForeignActivitiesInd>
      <MoreThan5000KToOrgInd>0</MoreThan5000KToOrgInd>
      <MoreThan5000KToIndividualsInd>0</MoreThan5000KToIndividualsInd>
      <ProfessionalFundraisingInd>0</ProfessionalFundraisingInd>
      <FundraisingActivitiesInd>0</FundraisingActivitiesInd>
      <GamingActivitiesInd>0</GamingActivitiesInd>
      <OperateHospitalInd>0</OperateHospitalInd>
      <GrantsToOrganizationsInd>0</GrantsToOrganizationsInd>
      <GrantsToIndividualsInd>0</GrantsToIndividualsInd>
      <ScheduleJRequiredInd>0</ScheduleJRequiredInd>
      <TaxExemptBondsInd>0</TaxExemptBondsInd>
      <EngagedInExcessBenefitTransInd>0</EngagedInExcessBenefitTransInd>
      <PYExcessBenefitTransInd>0</PYExcessBenefitTransInd>
      <LoanOutstandingInd>0</LoanOutstandingInd>
      <GrantToRelatedPersonInd>0</GrantToRelatedPersonInd>
      <BusinessRlnWithOrgMemInd>0</BusinessRlnWithOrgMemInd>
      <BusinessRlnWithFamMemInd>0</BusinessRlnWithFamMemInd>
      <BusinessRlnWithOfficerEntInd>0</BusinessRlnWithOfficerEntInd>
      <DeductibleNonCashContriInd referenceDocumentId="RetDoc1042900001">1</DeductibleNonCashContriInd>
      <DeductibleArtContributionInd referenceDocumentId="RetDoc1042900001">0</DeductibleArtContributionInd>
      <TerminateOperationsInd>0</TerminateOperationsInd>
      <PartialLiquidationInd>0</PartialLiquidationInd>
      <DisregardedEntityInd referenceDocumentId="RetDoc1043400001">1</DisregardedEntityInd>
      <RelatedEntityInd referenceDocumentId="RetDoc1043400001">0</RelatedEntityInd>
      <RelatedOrganizationCtrlEntInd>0</RelatedOrganizationCtrlEntInd>
      <TrnsfrExmptNonChrtblRltdOrgInd referenceDocumentId="RetDoc1043400001">0</TrnsfrExmptNonChrtblRltdOrgInd>
      <ActivitiesConductedPrtshpInd referenceDocumentId="RetDoc1043400001">0</ActivitiesConductedPrtshpInd>
      <ScheduleORequiredInd>1</ScheduleORequiredInd>
      <IRPDocumentCnt>12</IRPDocumentCnt>
      <IRPDocumentW2GCnt>0</IRPDocumentW2GCnt>
      <BackupWthldComplianceInd>1</BackupWthldComplianceInd>
      <EmployeeCnt>7</EmployeeCnt>
      <EmploymentTaxReturnsFiledInd>1</EmploymentTaxReturnsFiledInd>
      <UnrelatedBusIncmOverLimitInd>0</UnrelatedBusIncmOverLimitInd>
      <ForeignFinancialAccountInd>0</ForeignFinancialAccountInd>
      <ProhibitedTaxShelterTransInd>0</ProhibitedTaxShelterTransInd>
      <TaxablePartyNotificationInd>0</TaxablePartyNotificationInd>
      <NondeductibleContributionsInd>0</NondeductibleContributionsInd>
      <QuidProQuoContributionsInd>0</QuidProQuoContributionsInd>
      <Form8282PropertyDisposedOfInd>0</Form8282PropertyDisposedOfInd>
      <RcvFndsToPayPrsnlBnftCntrctInd>0</RcvFndsToPayPrsnlBnftCntrctInd>
      <PayPremiumsPrsnlBnftCntrctInd>0</PayPremiumsPrsnlBnftCntrctInd>
      <IndoorTanningServicesInd>0</IndoorTanningServicesInd>
      <InfoInScheduleOPartVIInd>X</InfoInScheduleOPartVIInd>
      <GoverningBodyVotingMembersCnt>7</GoverningBodyVotingMembersCnt>
      <IndependentVotingMemberCnt>7</IndependentVotingMemberCnt>
      <FamilyOrBusinessRlnInd>0</FamilyOrBusinessRlnInd>
      <DelegationOfMgmtDutiesInd>0</DelegationOfMgmtDutiesInd>
      <ChangeToOrgDocumentsInd>0</ChangeToOrgDocumentsInd>
      <MaterialDiversionOrMisuseInd>0</MaterialDiversionOrMisuseInd>
      <MembersOrStockholdersInd>0</MembersOrStockholdersInd>
      <ElectionOfBoardMembersInd>0</ElectionOfBoardMembersInd>
      <DecisionsSubjectToApprovaInd>0</DecisionsSubjectToApprovaInd>
      <MinutesOfGoverningBodyInd>1</MinutesOfGoverningBodyInd>
      <MinutesOfCommitteesInd>1</MinutesOfCommitteesInd>
      <OfficerMailingAddressInd>0</OfficerMailingAddressInd>
      <LocalChaptersInd>0</LocalChaptersInd>
      <Form990ProvidedToGvrnBodyInd>1</Form990ProvidedToGvrnBodyInd>
      <ConflictOfInterestPolicyInd>1</ConflictOfInterestPolicyInd>
      <AnnualDisclosureCoveredPrsnInd>1</AnnualDisclosureCoveredPrsnInd>
      <RegularMonitoringEnfrcInd>1</RegularMonitoringEnfrcInd>
      <WhistleblowerPolicyInd>0</WhistleblowerPolicyInd>
      <DocumentRetentionPolicyInd>1</DocumentRetentionPolicyInd>
      <CompensationProcessCEOInd>1</CompensationProcessCEOInd>
      <CompensationProcessOtherInd>0</CompensationProcessOtherInd>
      <InvestmentInJointVentureInd>0</InvestmentInJointVentureInd>
      <StatesWhereCopyOfReturnIsFldCd>CA</StatesWhereCopyOfReturnIsFldCd>
      <OtherWebsiteInd>X</OtherWebsiteInd>
      <BooksInCareOfDetail>
        <BusinessName>
          <BusinessNameLine1Txt>PATRICIA EGAN</BusinessNameLine1Txt>
        </BusinessName>
        <PhoneNum>5108091660</PhoneNum>
        <USAddress>
          <AddressLine1Txt>2288 FULTON ST 307</AddressLine1Txt>
          <CityNm>BERKELEY</CityNm>
          <StateAbbreviationCd>CA</StateAbbreviationCd>
          <ZIPCd>94704</ZIPCd>
        </USAddress>
      </BooksInCareOfDetail>
      <Form990PartVIISectionAGrp>
        <PersonNm>PATRICIA J EGAN MS MBA</PersonNm>
        <TitleTxt>BOARD CHAIR</TitleTxt>
        <AverageHoursPerWeekRt>40.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <OfficerInd>X</OfficerInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>MICHAEL CANNON MBA</PersonNm>
        <TitleTxt>VICE CHAIR</TitleTxt>
        <AverageHoursPerWeekRt>15.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <OfficerInd>X</OfficerInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>EVA SEVICK-MURACA PHD</PersonNm>
        <TitleTxt>TREASURER</TitleTxt>
        <AverageHoursPerWeekRt>15.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <OfficerInd>X</OfficerInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>NALINI MURDTER PHD</PersonNm>
        <TitleTxt>SECRETARY</TitleTxt>
        <AverageHoursPerWeekRt>2.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <OfficerInd>X</OfficerInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>WADE P FARROW MD CWSP FACCWS</PersonNm>
        <TitleTxt>DIRECTOR</TitleTxt>
        <AverageHoursPerWeekRt>2.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>KRIS L MASER JD</PersonNm>
        <TitleTxt>DIRECTOR</TitleTxt>
        <AverageHoursPerWeekRt>2.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>NICOLE L STOUT DPT CLT-LANA</PersonNm>
        <TitleTxt>DIRECTOR</TitleTxt>
        <AverageHoursPerWeekRt>2.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>SASKIA RJ THIADENS RN THRU 1204</PersonNm>
        <TitleTxt>EXECUTIVE DIRECTOR</TitleTxt>
        <AverageHoursPerWeekRt>40.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <OfficerInd>X</OfficerInd>
        <ReportableCompFromOrgAmt>119885</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <TotalReportableCompFromOrgAmt>119885</TotalReportableCompFromOrgAmt>
      <TotReportableCompRltdOrgAmt>0</TotReportableCompRltdOrgAmt>
      <TotalOtherCompensationAmt>0</TotalOtherCompensationAmt>
      <IndivRcvdGreaterThan100KCnt>1</IndivRcvdGreaterThan100KCnt>
      <FormerOfcrEmployeesListedInd>0</FormerOfcrEmployeesListedInd>
      <TotalCompGreaterThan150KInd>0</TotalCompGreaterThan150KInd>
      <CompensationFromOtherSrcsInd>0</CompensationFromOtherSrcsInd>
      <CntrctRcvdGreaterThan100KCnt>0</CntrctRcvdGreaterThan100KCnt>
      <AllOtherContributionsAmt>331129</AllOtherContributionsAmt>
      <NoncashContributionsAmt>180749</NoncashContributionsAmt>
      <TotalContributionsAmt>331129</TotalContributionsAmt>
      <ProgramServiceRevenueGrp>
        <Desc>CONFERENCE</Desc>
        <BusinessCd>900099</BusinessCd>
        <TotalRevenueColumnAmt>726618</TotalRevenueColumnAmt>
        <RelatedOrExemptFuncIncomeAmt>726618</RelatedOrExemptFuncIncomeAmt>
      </ProgramServiceRevenueGrp>
      <ProgramServiceRevenueGrp>
        <Desc>RESOURCE LISTING</Desc>
        <BusinessCd>900099</BusinessCd>
        <TotalRevenueColumnAmt>91066</TotalRevenueColumnAmt>
        <RelatedOrExemptFuncIncomeAmt>91066</RelatedOrExemptFuncIncomeAmt>
      </ProgramServiceRevenueGrp>
      <ProgramServiceRevenueGrp>
        <Desc>SUBCRIBERS/ MEMBERSHIP</Desc>
        <BusinessCd>900099</BusinessCd>
        <TotalRevenueColumnAmt>71766</TotalRevenueColumnAmt>
        <RelatedOrExemptFuncIncomeAmt>71766</RelatedOrExemptFuncIncomeAmt>
      </ProgramServiceRevenueGrp>
      <ProgramServiceRevenueGrp>
        <Desc>INFORMATIONAL DISPLAY</Desc>
        <BusinessCd>900099</BusinessCd>
        <TotalRevenueColumnAmt>61479</TotalRevenueColumnAmt>
        <RelatedOrExemptFuncIncomeAmt>61479</RelatedOrExemptFuncIncomeAmt>
      </ProgramServiceRevenueGrp>
      <TotalProgramServiceRevenueAmt>950929</TotalProgramServiceRevenueAmt>
      <InvestmentIncomeGrp>
        <TotalRevenueColumnAmt>234</TotalRevenueColumnAmt>
        <ExclusionAmt>234</ExclusionAmt>
      </InvestmentIncomeGrp>
      <GrossSalesOfInventoryAmt>10800</GrossSalesOfInventoryAmt>
      <CostOfGoodsSoldAmt>8649</CostOfGoodsSoldAmt>
      <NetIncomeOrLossGrp>
        <TotalRevenueColumnAmt>2151</TotalRevenueColumnAmt>
        <RelatedOrExemptFuncIncomeAmt>2151</RelatedOrExemptFuncIncomeAmt>
      </NetIncomeOrLossGrp>
      <TotalRevenueGrp>
        <TotalRevenueColumnAmt>1284443</TotalRevenueColumnAmt>
        <RelatedOrExemptFuncIncomeAmt>953080</RelatedOrExemptFuncIncomeAmt>
        <UnrelatedBusinessRevenueAmt>0</UnrelatedBusinessRevenueAmt>
        <ExclusionAmt>234</ExclusionAmt>
      </TotalRevenueGrp>
      <InfoInScheduleOPartIXInd>X</InfoInScheduleOPartIXInd>
      <GrantsToDomesticIndividualsGrp>
        <TotalAmt>3880</TotalAmt>
        <ProgramServicesAmt>3880</ProgramServicesAmt>
      </GrantsToDomesticIndividualsGrp>
      <CompCurrentOfcrDirectorsGrp>
        <TotalAmt>119885</TotalAmt>
        <ProgramServicesAmt>115755</ProgramServicesAmt>
        <ManagementAndGeneralAmt>2060</ManagementAndGeneralAmt>
        <FundraisingAmt>2070</FundraisingAmt>
      </CompCurrentOfcrDirectorsGrp>
      <OtherSalariesAndWagesGrp>
        <TotalAmt>103070</TotalAmt>
        <ProgramServicesAmt>99519</ProgramServicesAmt>
        <ManagementAndGeneralAmt>1771</ManagementAndGeneralAmt>
        <FundraisingAmt>1780</FundraisingAmt>
      </OtherSalariesAndWagesGrp>
      <OtherEmployeeBenefitsGrp>
        <TotalAmt>10816</TotalAmt>
        <ProgramServicesAmt>10443</ProgramServicesAmt>
        <ManagementAndGeneralAmt>186</ManagementAndGeneralAmt>
        <FundraisingAmt>187</FundraisingAmt>
      </OtherEmployeeBenefitsGrp>
      <PayrollTaxesGrp>
        <TotalAmt>21316</TotalAmt>
        <ProgramServicesAmt>20581</ProgramServicesAmt>
        <ManagementAndGeneralAmt>366</ManagementAndGeneralAmt>
        <FundraisingAmt>369</FundraisingAmt>
      </PayrollTaxesGrp>
      <FeesForServicesLegalGrp>
        <TotalAmt>12285</TotalAmt>
        <ProgramServicesAmt>8367</ProgramServicesAmt>
        <ManagementAndGeneralAmt>3918</ManagementAndGeneralAmt>
      </FeesForServicesLegalGrp>
      <FeesForServicesAccountingGrp>
        <TotalAmt>15077</TotalAmt>
        <ProgramServicesAmt>1150</ProgramServicesAmt>
        <ManagementAndGeneralAmt>13927</ManagementAndGeneralAmt>
      </FeesForServicesAccountingGrp>
      <FeesForServicesOtherGrp>
        <TotalAmt>244579</TotalAmt>
        <ProgramServicesAmt>204546</ProgramServicesAmt>
        <ManagementAndGeneralAmt>40012</ManagementAndGeneralAmt>
        <FundraisingAmt>21</FundraisingAmt>
      </FeesForServicesOtherGrp>
      <OfficeExpensesGrp>
        <TotalAmt>22120</TotalAmt>
        <ProgramServicesAmt>18003</ProgramServicesAmt>
        <ManagementAndGeneralAmt>3754</ManagementAndGeneralAmt>
        <FundraisingAmt>363</FundraisingAmt>
      </OfficeExpensesGrp>
      <OccupancyGrp>
        <TotalAmt>64141</TotalAmt>
        <ProgramServicesAmt>49337</ProgramServicesAmt>
        <ManagementAndGeneralAmt>12338</ManagementAndGeneralAmt>
        <FundraisingAmt>2466</FundraisingAmt>
      </OccupancyGrp>
      <TravelGrp>
        <TotalAmt>5697</TotalAmt>
        <ProgramServicesAmt>5291</ProgramServicesAmt>
        <ManagementAndGeneralAmt>29</ManagementAndGeneralAmt>
        <FundraisingAmt>377</FundraisingAmt>
      </TravelGrp>
      <ConferencesMeetingsGrp>
        <TotalAmt>593894</TotalAmt>
        <ProgramServicesAmt>592810</ProgramServicesAmt>
        <ManagementAndGeneralAmt>1084</ManagementAndGeneralAmt>
      </ConferencesMeetingsGrp>
      <DepreciationDepletionGrp>
        <TotalAmt>10000</TotalAmt>
        <ProgramServicesAmt>7700</ProgramServicesAmt>
        <ManagementAndGeneralAmt>1900</ManagementAndGeneralAmt>
        <FundraisingAmt>400</FundraisingAmt>
      </DepreciationDepletionGrp>
      <InsuranceGrp>
        <TotalAmt>3617</TotalAmt>
        <ProgramServicesAmt>3493</ProgramServicesAmt>
        <ManagementAndGeneralAmt>62</ManagementAndGeneralAmt>
        <FundraisingAmt>62</FundraisingAmt>
      </InsuranceGrp>
      <OtherExpensesGrp>
        <Desc>GARMENT FUND DONATIONS</Desc>
        <TotalAmt>180749</TotalAmt>
        <ProgramServicesAmt>180749</ProgramServicesAmt>
      </OtherExpensesGrp>
      <OtherExpensesGrp>
        <Desc>FINANCE CHARGE AND FEES</Desc>
        <TotalAmt>41224</TotalAmt>
        <ProgramServicesAmt>32307</ProgramServicesAmt>
        <ManagementAndGeneralAmt>8917</ManagementAndGeneralAmt>
      </OtherExpensesGrp>
      <OtherExpensesGrp>
        <Desc>PRINTING</Desc>
        <TotalAmt>30674</TotalAmt>
        <ProgramServicesAmt>30674</ProgramServicesAmt>
      </OtherExpensesGrp>
      <OtherExpensesGrp>
        <Desc>POSTAGE</Desc>
        <TotalAmt>25050</TotalAmt>
        <ProgramServicesAmt>25050</ProgramServicesAmt>
      </OtherExpensesGrp>
      <AllOtherExpensesGrp>
        <TotalAmt>6596</TotalAmt>
        <ProgramServicesAmt>5259</ProgramServicesAmt>
        <ManagementAndGeneralAmt>916</ManagementAndGeneralAmt>
        <FundraisingAmt>421</FundraisingAmt>
      </AllOtherExpensesGrp>
      <TotalFunctionalExpensesGrp>
        <TotalAmt>1514670</TotalAmt>
        <ProgramServicesAmt>1414914</ProgramServicesAmt>
        <ManagementAndGeneralAmt>91240</ManagementAndGeneralAmt>
        <FundraisingAmt>8516</FundraisingAmt>
      </TotalFunctionalExpensesGrp>
      <CashNonInterestBearingGrp>
        <BOYAmt>86211</BOYAmt>
        <EOYAmt>22781</EOYAmt>
      </CashNonInterestBearingGrp>
      <SavingsAndTempCashInvstGrp>
        <BOYAmt>355570</BOYAmt>
        <EOYAmt>146944</EOYAmt>
      </SavingsAndTempCashInvstGrp>
      <AccountsReceivableGrp>
        <BOYAmt>43413</BOYAmt>
        <EOYAmt>7290</EOYAmt>
      </AccountsReceivableGrp>
      <InventoriesForSaleOrUseGrp>
        <BOYAmt>32882</BOYAmt>
        <EOYAmt>24952</EOYAmt>
      </InventoriesForSaleOrUseGrp>
      <PrepaidExpensesDefrdChargesGrp>
        <BOYAmt>30259</BOYAmt>
        <EOYAmt>25570</EOYAmt>
      </PrepaidExpensesDefrdChargesGrp>
      <LandBldgEquipCostOrOtherBssAmt>81351</LandBldgEquipCostOrOtherBssAmt>
      <LandBldgEquipAccumDeprecAmt>56043</LandBldgEquipAccumDeprecAmt>
      <LandBldgEquipBasisNetGrp>
        <BOYAmt>35307</BOYAmt>
        <EOYAmt>25308</EOYAmt>
      </LandBldgEquipBasisNetGrp>
      <OtherAssetsTotalGrp>
        <BOYAmt>3892</BOYAmt>
        <EOYAmt>6191</EOYAmt>
      </OtherAssetsTotalGrp>
      <TotalAssetsGrp>
        <BOYAmt>587534</BOYAmt>
        <EOYAmt>259036</EOYAmt>
      </TotalAssetsGrp>
      <AccountsPayableAccrExpnssGrp>
        <BOYAmt>24301</BOYAmt>
        <EOYAmt>33906</EOYAmt>
      </AccountsPayableAccrExpnssGrp>
      <DeferredRevenueGrp>
        <BOYAmt>232625</BOYAmt>
        <EOYAmt>145495</EOYAmt>
      </DeferredRevenueGrp>
      <OtherLiabilitiesGrp>
        <BOYAmt>20746</BOYAmt>
        <EOYAmt>0</EOYAmt>
      </OtherLiabilitiesGrp>
      <TotalLiabilitiesGrp>
        <BOYAmt>277672</BOYAmt>
        <EOYAmt>179401</EOYAmt>
      </TotalLiabilitiesGrp>
      <OrganizationFollowsSFAS117Ind>X</OrganizationFollowsSFAS117Ind>
      <UnrestrictedNetAssetsGrp>
        <BOYAmt>260768</BOYAmt>
        <EOYAmt>7941</EOYAmt>
      </UnrestrictedNetAssetsGrp>
      <TemporarilyRstrNetAssetsGrp>
        <BOYAmt>49094</BOYAmt>
        <EOYAmt>71694</EOYAmt>
      </TemporarilyRstrNetAssetsGrp>
      <TotalNetAssetsFundBalanceGrp>
        <BOYAmt>309862</BOYAmt>
        <EOYAmt>79635</EOYAmt>
      </TotalNetAssetsFundBalanceGrp>
      <TotLiabNetAssetsFundBalanceGrp>
        <BOYAmt>587534</BOYAmt>
        <EOYAmt>259036</EOYAmt>
      </TotLiabNetAssetsFundBalanceGrp>
      <ReconcilationRevenueExpnssAmt>-230227</ReconcilationRevenueExpnssAmt>
      <OtherChangesInNetAssetsAmt>0</OtherChangesInNetAssetsAmt>
      <InfoInScheduleOPartXIIInd>X</InfoInScheduleOPartXIIInd>
      <MethodOfAccountingAccrualInd>X</MethodOfAccountingAccrualInd>
      <AccountantCompileOrReviewInd>0</AccountantCompileOrReviewInd>
      <FSAuditedInd>1</FSAuditedInd>
      <FSAuditedBasisGrp>
        <ConsolidatedBasisFinclStmtInd>X</ConsolidatedBasisFinclStmtInd>
      </FSAuditedBasisGrp>
      <AuditCommitteeInd>1</AuditCommitteeInd>
      <FederalGrantAuditRequiredInd>0</FederalGrantAuditRequiredInd>
    </IRS990>
    <IRS990ScheduleA documentId="RetDoc1039100001">
      <PubliclySupportedOrg509a2Ind>X</PubliclySupportedOrg509a2Ind>
      <GiftsGrantsContrisRcvd509Grp>
        <CurrentTaxYearMinus4YearsAmt>122788</CurrentTaxYearMinus4YearsAmt>
        <CurrentTaxYearMinus3YearsAmt>228011</CurrentTaxYearMinus3YearsAmt>
        <CurrentTaxYearMinus2YearsAmt>103617</CurrentTaxYearMinus2YearsAmt>
        <CurrentTaxYearMinus1YearAmt>148069</CurrentTaxYearMinus1YearAmt>
        <CurrentTaxYearAmt>331129</CurrentTaxYearAmt>
        <TotalAmt>933614</TotalAmt>
      </GiftsGrantsContrisRcvd509Grp>
      <GrossReceiptsAdmissionsGrp>
        <CurrentTaxYearMinus4YearsAmt>179348</CurrentTaxYearMinus4YearsAmt>
        <CurrentTaxYearMinus3YearsAmt>803693</CurrentTaxYearMinus3YearsAmt>
        <CurrentTaxYearMinus2YearsAmt>255430</CurrentTaxYearMinus2YearsAmt>
        <CurrentTaxYearMinus1YearAmt>916163</CurrentTaxYearMinus1YearAmt>
        <CurrentTaxYearAmt>953080</CurrentTaxYearAmt>
        <TotalAmt>3107714</TotalAmt>
      </GrossReceiptsAdmissionsGrp>
      <Total509Grp>
        <CurrentTaxYearMinus4YearsAmt>302136</CurrentTaxYearMinus4YearsAmt>
        <CurrentTaxYearMinus3YearsAmt>1031704</CurrentTaxYearMinus3YearsAmt>
        <CurrentTaxYearMinus2YearsAmt>359047</CurrentTaxYearMinus2YearsAmt>
        <CurrentTaxYearMinus1YearAmt>1064232</CurrentTaxYearMinus1YearAmt>
        <CurrentTaxYearAmt>1284209</CurrentTaxYearAmt>
        <TotalAmt>4041328</TotalAmt>
      </Total509Grp>
      <AmountsRcvdDsqlfyPersonGrp>
        <TotalAmt>0</TotalAmt>
      </AmountsRcvdDsqlfyPersonGrp>
      <SubstantialContributorsAmtGrp>
        <CurrentTaxYearMinus3YearsAmt>100266</CurrentTaxYearMinus3YearsAmt>
        <CurrentTaxYearMinus2YearsAmt>68750</CurrentTaxYearMinus2YearsAmt>
        <CurrentTaxYearMinus1YearAmt>73040</CurrentTaxYearMinus1YearAmt>
        <TotalAmt>242056</TotalAmt>
      </SubstantialContributorsAmtGrp>
      <SubstAndDsqlfyPrsnsTotGrp>
        <CurrentTaxYearMinus3YearsAmt>100266</CurrentTaxYearMinus3YearsAmt>
        <CurrentTaxYearMinus2YearsAmt>68750</CurrentTaxYearMinus2YearsAmt>
        <CurrentTaxYearMinus1YearAmt>73040</CurrentTaxYearMinus1YearAmt>
        <TotalAmt>242056</TotalAmt>
      </SubstAndDsqlfyPrsnsTotGrp>
      <PublicSupportTotal509Amt>3799272</PublicSupportTotal509Amt>
      <GrossInvestmentIncome509Grp>
        <CurrentTaxYearMinus4YearsAmt>364</CurrentTaxYearMinus4YearsAmt>
        <CurrentTaxYearMinus3YearsAmt>1121</CurrentTaxYearMinus3YearsAmt>
        <CurrentTaxYearMinus2YearsAmt>327</CurrentTaxYearMinus2YearsAmt>
        <CurrentTaxYearMinus1YearAmt>408</CurrentTaxYearMinus1YearAmt>
        <CurrentTaxYearAmt>234</CurrentTaxYearAmt>
        <TotalAmt>2454</TotalAmt>
      </GrossInvestmentIncome509Grp>
      <InvestmentIncomeAndUBTIGrp>
        <CurrentTaxYearMinus4YearsAmt>364</CurrentTaxYearMinus4YearsAmt>
        <CurrentTaxYearMinus3YearsAmt>1121</CurrentTaxYearMinus3YearsAmt>
        <CurrentTaxYearMinus2YearsAmt>327</CurrentTaxYearMinus2YearsAmt>
        <CurrentTaxYearMinus1YearAmt>408</CurrentTaxYearMinus1YearAmt>
        <CurrentTaxYearAmt>234</CurrentTaxYearAmt>
        <TotalAmt>2454</TotalAmt>
      </InvestmentIncomeAndUBTIGrp>
      <OtherIncome509Grp>
        <CurrentTaxYearMinus1YearAmt>1898</CurrentTaxYearMinus1YearAmt>
        <TotalAmt>1898</TotalAmt>
      </OtherIncome509Grp>
      <TotalSupportCalendarYearGrp>
        <CurrentTaxYearMinus4YearsAmt>302500</CurrentTaxYearMinus4YearsAmt>
        <CurrentTaxYearMinus3YearsAmt>1032825</CurrentTaxYearMinus3YearsAmt>
        <CurrentTaxYearMinus2YearsAmt>359374</CurrentTaxYearMinus2YearsAmt>
        <CurrentTaxYearMinus1YearAmt>1066538</CurrentTaxYearMinus1YearAmt>
        <CurrentTaxYearAmt>1284443</CurrentTaxYearAmt>
        <TotalAmt>4045680</TotalAmt>
      </TotalSupportCalendarYearGrp>
      <PublicSupportCY509Pct>0.93910</PublicSupportCY509Pct>
      <PublicSupportPY509Pct>0.90410</PublicSupportPY509Pct>
      <InvestmentIncomeCYPct>0.00060</InvestmentIncomeCYPct>
      <InvestmentIncomePYPct>0.00100</InvestmentIncomePYPct>
      <ThirtyThrPctSuprtTestsCY509Ind>X</ThirtyThrPctSuprtTestsCY509Ind>
    </IRS990ScheduleA>
    <IRS990ScheduleB documentId="RetDoc1234500001">
      <ContributorInformationGrp>
        <ContributorNum>RESTRICTED</ContributorNum>
        <ContributorBusinessName>
          <BusinessNameLine1>RESTRICTED</BusinessNameLine1>
        </ContributorBusinessName>
        <ContributorUSAddress>
          <AddressLine1>RESTRICTED</AddressLine1>
          <AddressLine2>RESTRICTED</AddressLine2>
          <City>RESTRICTED</City>
          <State>RESTRICTED</State>
          <ZIPCode>RESTRICTED</ZIPCode>
        </ContributorUSAddress>
        <TotalContributionsAmt>RESTRICTED</TotalContributionsAmt>
      </ContributorInformationGrp>
    </IRS990ScheduleB>
    <IRS990ScheduleC documentId="RetDoc1039500001">
      <PoliticalExpendituresAmt>0</PoliticalExpendituresAmt>
      <VolunteersInd>1</VolunteersInd>
      <PaidStaffOrManagementInd>0</PaidStaffOrManagementInd>
      <MediaAdvertisementsInd>0</MediaAdvertisementsInd>
      <MailingsMembersInd>0</MailingsMembersInd>
      <PublicationsOrBroadcastInd>0</PublicationsOrBroadcastInd>
      <GrantsOtherOrganizationsInd>0</GrantsOtherOrganizationsInd>
      <DirectContactLegislatorsInd>1</DirectContactLegislatorsInd>
      <RalliesDemonstrationsInd>0</RalliesDemonstrationsInd>
      <OtherActivitiesInd>0</OtherActivitiesInd>
      <TotalLobbyingExpendituresAmt>0</TotalLobbyingExpendituresAmt>
      <NotDescribedSection501c3Ind>0</NotDescribedSection501c3Ind>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>PART II-B</FormAndLineReferenceDesc>
        <ExplanationTxt>IN KEEPING WITH ITS MISSION TO PROMOTE AND SUPPORT THE AVAILABILITY OF QUALITY MEDICAL TREATMENT FOR ALL INDIVIDUALS AT RISK FOR OR AFFECTED BY LYMPHEDEMA, THE NATIONAL LYMPHEDEMA NETWORK ENGAGES IN ADVOCACY EFFORTS, INCLUDING LOBBYING FOR THE PASSAGE OF LEGISLATION SUCH AS THE LYMPHEDEMA TREATMENT ACT. LOBBYING EFFORTS INCLUDE LETTERS OF SUPPORT, NEWS UPDATES, COOPERATION WITH OTHER LIKE-PURPOSED ORGANIZATIONS, AND MEETING WITH LEGISLATORS TO DISCUSS POLICIES AND PENDING LEGISLATION RELATED TO PATIENT NEEDS. GIVEN THAT THE NLN'S PRIMARY ACTIVITIES SUPPORT EDUCATION, AWARENESS, AND DISSEMINATION OF INFORMATION ABOUT LYMPHEDEMA, OUR ACTIVITIES THAT COULD BE CHARACTERIZED AS LOBBYING ARE LIMITED TO A MODEST LEVEL.</ExplanationTxt>
      </SupplementalInformationDetail>
    </IRS990ScheduleC>
    <IRS990ScheduleD documentId="RetDoc1040000001">
      <OtherLandBuildingsGrp>
        <OtherCostOrOtherBasisAmt>81351</OtherCostOrOtherBasisAmt>
        <DepreciationAmt>56043</DepreciationAmt>
        <BookValueAmt>25308</BookValueAmt>
      </OtherLandBuildingsGrp>
      <TotalBookValueLandBuildingsAmt>25308</TotalBookValueLandBuildingsAmt>
      <FootnoteTextInd>X</FootnoteTextInd>
      <TotalRevEtcAuditedFinclStmtAmt>562900</TotalRevEtcAuditedFinclStmtAmt>
      <OtherRevenueAmt>8649</OtherRevenueAmt>
      <RevenueNotReportedAmt>8649</RevenueNotReportedAmt>
      <RevenueSubtotalAmt>554251</RevenueSubtotalAmt>
      <OtherRevenuesNotIncludedAmt>730192</OtherRevenuesNotIncludedAmt>
      <RevenueNotReportedFinclStmtAmt>730192</RevenueNotReportedFinclStmtAmt>
      <TotalRevenuePerForm990Amt>1284443</TotalRevenuePerForm990Amt>
      <TotExpnsEtcAuditedFinclStmtAmt>719100</TotExpnsEtcAuditedFinclStmtAmt>
      <OtherExpensesIncludedAmt>8649</OtherExpensesIncludedAmt>
      <ExpensesNotReportedAmt>8649</ExpensesNotReportedAmt>
      <ExpensesSubtotalAmt>710451</ExpensesSubtotalAmt>
      <OtherExpensesNotIncludedAmt>804219</OtherExpensesNotIncludedAmt>
      <ExpensesNotRptFinclStmtAmt>804219</ExpensesNotRptFinclStmtAmt>
      <TotalExpensesPerForm990Amt>1514670</TotalExpensesPerForm990Amt>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>PART X, LINE 2:</FormAndLineReferenceDesc>
        <ExplanationTxt>THE ORGANIZATION HAS APPLIED THE ACCOUNTING PRINCIPLES RELATED TO ACCOUNTING FOR UNCERTAINTY IN INCOME TAXES AND HAS DETERMINED THAT THERE IS NO MATERIAL IMPACT ON THE FINANCIAL STATEMENTS. WITH SOME EXCEPTIONS, THE ORGANIZATION IS NO LONGER SUBJECT TO U.S. FEDERAL AND STATE INCOME TAX EXAMINATIONS BY TAX AUTHORITIES FOR YEARS PRIOR TO 2011.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>PART XI, LINE 2D - OTHER ADJUSTMENTS:</FormAndLineReferenceDesc>
        <ExplanationTxt>COST OF PRODUCT SALES 8,649.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>PART XI, LINE 4B - OTHER ADJUSTMENTS:</FormAndLineReferenceDesc>
        <ExplanationTxt>REVENUE FROM DISCONTINUED OPERATIONS - DISREGARDED ENTITY 730,192.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>PART XII, LINE 2D - OTHER ADJUSTMENTS:</FormAndLineReferenceDesc>
        <ExplanationTxt>COST OF PRODUCT SALES 8,649.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>PART XII, LINE 4B - OTHER ADJUSTMENTS:</FormAndLineReferenceDesc>
        <ExplanationTxt>EXPENSE FROM DISCONTINUED OPERATIONS - DISREGARDED ENTITY 804,219.</ExplanationTxt>
      </SupplementalInformationDetail>
    </IRS990ScheduleD>
    <IRS990ScheduleM documentId="RetDoc1042900001">
      <OtherNonCashContriTableGrp>
        <NonCashCheckboxInd>X</NonCashCheckboxInd>
        <Desc>COMPRESSION GARMENTS</Desc>
        <ContributionCnt>336</ContributionCnt>
        <NoncashContributionsRptF990Amt>180749</NoncashContributionsRptF990Amt>
        <MethodOfDeterminingRevenuesTxt>FMV</MethodOfDeterminingRevenuesTxt>
      </OtherNonCashContriTableGrp>
      <Form8283ReceivedCnt>0</Form8283ReceivedCnt>
      <AnyPropertyThatMustBeHeldInd>0</AnyPropertyThatMustBeHeldInd>
      <ReviewProcessUnusualNCGiftsInd>0</ReviewProcessUnusualNCGiftsInd>
      <ThirdPartiesUsedInd>0</ThirdPartiesUsedInd>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>PART I, COLUMN (B):</FormAndLineReferenceDesc>
        <ExplanationTxt>THE ORGANIZATION TRACKS BOTH THE NUMBER OF PATIENTS WHO RECEIVED COMPRESSION GARMENTS AND THE NUMBER OF GARMENTS DISTRIBUTED. THE "PATIENT" NUMBER IS USED TO REPRESENT THE NUMBER OF CONTRIBUTIONS AND ACTIVITY OF THE FUND BECAUSE MEDICAL NECESSITY DIFFERS FROM PATIENT TO PATIENT; SOME PATIENTS REQUIRE COMPLEX SETS OF GARMENTS WITH EXTRA COMPONENTS WHEREAS OTHERS MAY ONLY REQUIRE ONE ITEM.</ExplanationTxt>
      </SupplementalInformationDetail>
    </IRS990ScheduleM>
    <IRS990ScheduleO documentId="RetDoc1044400001">
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, PART VI, SECTION B, LINE 11</FormAndLineReferenceDesc>
        <ExplanationTxt>THE ANNUAL IRS FORM 990 IS PREPARED BY THE NLN'S PROFESSIONAL CPA FIRM AND TAX ADVISOR. THE DRAFT IS REVIEWED BY THE BUSINESS MANAGER, EXECUTIVE DIRECTOR, AND BOARD CHAIR, THEN DISCUSSED DURING A CONFERENCE CALL WITH THE ENTIRE BOARD OF DIRECTORS. THE CPA PRESENTS THE AUDIT, MANAGEMENT LETTER, AND FORM 990 TO THE BOARD, DISCUSSES ANY CURRENT ISSUES, AND HANDLES QUESTIONS BY BOARD MEMBERS. FOLLOWING A FULL REVIEW OF THE COMPLETE FORM 990, THE BOARD VOTES TO APPROVE THE RETURN WITH ANY MODIFICATIONS NOTED. THE EXECUTIVE DIRECTOR SIGNS THE FORM 990, WHICH THE CPA SUBMITS ELECTRONICALLY TO THE INTERNAL REVENUE SERVICE, DEPARTMENT OF TREASURY.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, PART VI, SECTION B, LINE 12C</FormAndLineReferenceDesc>
        <ExplanationTxt>WHEN A NEW MEMBER JOINS THE BOARD OF DIRECTORS, HE OR SHE IS REQUIRED TO REVIEW THE CONFLICT OF INTEREST POLICY AND COMPLETE THE STATEMENT TO DISCLOSE ASSOCIATIONS AND RELATIONSHIPS. EACH YEAR, AT THE ANNUAL MEETING OF THE BOARD OF DIRECTORS, BOARD MEMBERS COMPLETE A FRESH CONFLICT OF INTEREST DISCLOSURE STATEMENT. ALL CONFLICT OF INTEREST DISCLOSURES ARE REVIEWED BY THE BOARD CHAIR AND EXECUTIVE DIRECTOR TO DETERMINE IF ANY CONFLICTS EXIST. SHOULD THERE BE QUESTIONS, THE BOARD CHAIR AND EXECUTIVE DIRECTOR CONSULT WITH LEGAL COUNSEL. IN THE CASE OF A TRUE CONFLICT OF INTEREST, THE BOARD DISCUSSES THE SITUATION AND RESOLVES WHETHER OR NOT TO REMOVE THE BOARD MEMBER. ALL CONFLICTS OF INTEREST ARE ADDRESSED IN A TIMELY MANNER.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, PART VI, SECTION B, LINE 15A</FormAndLineReferenceDesc>
        <ExplanationTxt>THE NLN COMPENSATES ITS EXECUTIVE DIRECTOR, WHO IS THE TOP MANAGEMENT OFFICIAL AND A VOTING MEMBER OF THE BOARD OF DIRECTORS. IN 2015, THERE WERE NO KEY EMPLOYEES OR HIGHLY COMPENSATED EMPLOYEES. IN ACCORDANCE WITH IRS RULES AND REGULATIONS, THE BOARD CHAIR CONDUCTS A COMPENSATION COMPARISON EVALUATION TO ENSURE THAT THE TOP MANAGEMENT OFFICIAL IS PAID A COMPETITIVE AND APPROPRIATE SALARY IN KEEPING WITH THOSE OF OTHER NONPROFIT ORGANIZATIONS OF COMPARABLE SIZE, GEOGRAPHIC REGION, LEVEL OF RESPONSIBILITY, AND DISCIPLINE. THE BOARD CHAIR USES PUBLISHED STUDIES BY CHARITY NAVIGATOR AND THE NONPROFIT TIMES AS RESOURCES FOR THE COMPENSATION EVALUATION. IN ADDITION, COST OF LIVING ADJUSTMENTS ARE MADE IN KEEPING WITH THE GUIDELINES ISSUED BY THE SOCIAL SECURITY ADMINISTRATION. THE COMPENSATION IS THEN CIRCULATED TO THE ENTIRE INDEPENDENT BOARD FOR REVIEW, DISCUSSION, AND APPROVAL WITHOUT THE PRESENCE OF THE TOP MANAGEMENT OFFICIAL, WHO IS NOT INDEPENDENT IN THIS MATTER. EVERY EFFORT IS MADE TO ENSURE THAT THE PROCESS IS THOROUGH, TRANSPARENT, AND IN ACCORDANCE WITH IRS GUIDELINES. ON AN ANNUAL BASIS, THE BOARD CONDUCTS A FORMAL EVALUATION OF THE EXECUTIVE DIRECTOR'S PERFORMANCE.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, PART VI, SECTION C, LINE 19</FormAndLineReferenceDesc>
        <ExplanationTxt>THE NLN MAKES ALL GOVERNING DOCUMENTS, FINANCIAL STATEMENTS, AND TAX RETURNS AVAILABLE FOR INSPECTION BY COMPLIANCE AUTHORITIES AND THE GENERAL PUBLIC ONSITE AT ITS OFFICE IN BERKELEY, CALIFORNIA. IN ADDITION, GOVERNING DOCUMENTS, INCLUDING THE IRS FORM 990, ARE AVAILABLE ONLINE VIA GUIDESTAR AND THE CALIFORNIA OFFICE OF THE ATTORNEY GENERAL'S CHARITY REGISTRATION WEBSITE. THE NLN IS RATED AS GUIDESTAR SILVER, WHICH MEANS THAT INFORMATION IS AVAILABLE ABOUT ITS PROGRAMS, MANAGEMENT, GOVERNANCE, AND COMPLIANCE. IN ADDITION, ALL BOARD MEMBERS HAVE THESE DOCUMENTS IN HAND IN THEIR BOARD BOOKS. UPON REQUEST, THE NLN WILL PROVIDE PUBLIC DOCUMENTS TO INQUIRERS.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, PART IX, LINE 11G</FormAndLineReferenceDesc>
        <ExplanationTxt>OTHER SERVICES: PROGRAM SERVICE EXPENSES 135,409. MANAGEMENT AND GENERAL EXPENSES 10,168. FUNDRAISING EXPENSES 21. TOTAL EXPENSES 145,598. CONTRACT SERVICES: PROGRAM SERVICE EXPENSES 63,731. MANAGEMENT AND GENERAL EXPENSES 29,844. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 93,575. GRAPHIC DESIGN: PROGRAM SERVICE EXPENSES 5,406. MANAGEMENT AND GENERAL EXPENSES 0. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 5,406.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, PART XII, LINE 2C</FormAndLineReferenceDesc>
        <ExplanationTxt>THIS PROCESS HAS NOT CHANGED FROM PRIOR YEAR.</ExplanationTxt>
      </SupplementalInformationDetail>
    </IRS990ScheduleO>
    <IRS990ScheduleR documentId="RetDoc1043400001">
      <IdDisregardedEntitiesGrp>
        <DisregardedEntityName>
          <BusinessNameLine1Txt>25TH WORLD CONGRESS OF LYMPHOLOGY LLC</BusinessNameLine1Txt>
        </DisregardedEntityName>
        <USAddress>
          <AddressLine1Txt>2288 FULTON STREET SUITE 307</AddressLine1Txt>
          <CityNm>BERKELEY</CityNm>
          <StateAbbreviationCd>CA</StateAbbreviationCd>
          <ZIPCd>94704</ZIPCd>
        </USAddress>
        <EIN>943068338</EIN>
        <PrimaryActivitiesTxt>WORLD CONFERENCE ON LYMPHOLOGY</PrimaryActivitiesTxt>
        <LegalDomicileStateCd>CA</LegalDomicileStateCd>
        <TotalIncomeAmt>-74027</TotalIncomeAmt>
        <EndOfYearAssetsAmt>1784</EndOfYearAssetsAmt>
        <DirectControllingEntityName>
          <BusinessNameLine1Txt>NATIONAL LYMPHEDEMA NETWORK INC</BusinessNameLine1Txt>
        </DirectControllingEntityName>
      </IdDisregardedEntitiesGrp>
      <ReceiptOfIntAnntsRntsRyltsInd>0</ReceiptOfIntAnntsRntsRyltsInd>
      <GiftGrntOrCapContriToOthOrgInd>0</GiftGrntOrCapContriToOthOrgInd>
      <GiftGrntCapContriFromOthOrgInd>0</GiftGrntCapContriFromOthOrgInd>
      <LoansOrGuaranteesToOtherOrgInd>0</LoansOrGuaranteesToOtherOrgInd>
      <LoansOrGuaranteesFromOthOrgInd>0</LoansOrGuaranteesFromOthOrgInd>
      <DivRelatedOrganizationInd>0</DivRelatedOrganizationInd>
      <AssetSaleToOtherOrgInd>0</AssetSaleToOtherOrgInd>
      <AssetPurchaseFromOtherOrgInd>0</AssetPurchaseFromOtherOrgInd>
      <AssetExchangeInd>0</AssetExchangeInd>
      <RentalOfFacilitiesToOthOrgInd>0</RentalOfFacilitiesToOthOrgInd>
      <RentalOfFcltsFromOthOrgInd>0</RentalOfFcltsFromOthOrgInd>
      <PerformOfServicesForOthOrgInd>1</PerformOfServicesForOthOrgInd>
      <PerformOfServicesByOtherOrgInd>0</PerformOfServicesByOtherOrgInd>
      <SharingOfFacilitiesInd>1</SharingOfFacilitiesInd>
      <PaidEmployeesSharingInd>1</PaidEmployeesSharingInd>
      <ReimbursementPaidToOtherOrgInd>0</ReimbursementPaidToOtherOrgInd>
      <ReimbursementPaidByOtherOrgInd>0</ReimbursementPaidByOtherOrgInd>
      <TransferToOtherOrgInd>1</TransferToOtherOrgInd>
      <TransferFromOtherOrgInd>0</TransferFromOtherOrgInd>
      <TransactionsRelatedOrgGrp>
        <OtherOrganizationName>
          <BusinessNameLine1Txt>25TH WORLD CONGRESS OF LYMPHOLOGY LLC</BusinessNameLine1Txt>
        </OtherOrganizationName>
        <TransactionTypeTxt>O</TransactionTypeTxt>
        <InvolvedAmt>51400</InvolvedAmt>
        <MethodOfAmountDeterminationTxt>ACTUAL COST</MethodOfAmountDeterminationTxt>
      </TransactionsRelatedOrgGrp>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>PART I</FormAndLineReferenceDesc>
        <ExplanationTxt>THE NATIONAL LYMPHEDEMA NETWORK WAS THE 100% SINGLE OWNER OF THE 25TH WORLD CONGRESS OF LYMPHOLOGY LLC, ESTABLISHED IN 2013 FOR THE PURPOSE OF PRODUCING A MEDICAL EDUCATION CONFERENCE IN SEPTEMBER 2015. AS SUCH, THE NATIONAL LYMPHEDEMA NETWORK CONTRIBUTED USE OF SPACE, EQUIPMENT, MATERIALS, INFUSIONS OF CASH AND PERSONNEL LABOR FROM THE INCEPTION OF THE LLC THROUGH THE PRODUCTION OF THE CONFERENCE EVENT ITSELF.</ExplanationTxt>
      </SupplementalInformationDetail>
    </IRS990ScheduleR>
  </ReturnData>
</Return>